In the present study, we estimated the impact of NMDAR1-abs seropositivity on global cognitive function and various subdomains of cognitive function using high-quality prospective data from the Determinants of Dementia After Stroke (DEMDAS) study. The gene discussed is GRIN1; the disease is Stroke.